Clinical Research

Ribocure Pharmaceuticals AB

Address
Vetenskapens Grand 11

Sponsor Overview

assignment
5
sponsored trials
science
6
molecules
location_city
27
research centres
public
4
countries
person_search
31
investigators

Specializations

Hepatitis D virus and liver disease

Research activity includes therapies for chronic hepatitis D virus infection, with interest in viral RNA reduction and treatment options for persistent HDV infection.

  • Chronic hepatitis D virus infection
  • HDV RNA
  • Antiviral therapy

The sponsor’s work in this area is centered on hepatology and the management of viral liver disease.

Complement-mediated diseases

Clinical research also covers complement system-related conditions, reflecting interest in inflammatory and immune-driven disorders linked to complement dysregulation.

  • Complement-mediated diseases
  • Complement inhibition
  • Immune-mediated disease

This area aligns with therapeutic development in immunology and inflammatory disease.

Lipid disorders

The sponsor is active in mixed dyslipidemia, with research focused on abnormal lipid metabolism and treatment of elevated or imbalanced blood lipids.

  • Mixed dyslipidemia
  • Lipid lowering
  • Cardiometabolic risk

These studies place emphasis on cardiovascular prevention and metabolic health.

Cardiovascular disease

Research includes stable coronary artery disease, with attention to chronic atherosclerotic cardiovascular disease and ongoing antiplatelet-treated populations.

  • Stable coronary artery disease
  • Atherosclerosis
  • Cardiovascular therapeutics

The sponsor’s cardiovascular focus spans ischemic heart disease and related long-term management.

Sponsored Trials

Trial Name Country Status
Efficacy and Safety Evaluation of RBD5044 Sodium in Patients with Mixed Dyslipidemia: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialPoland PolandSweden SwedenRecruiting
Efficacy, Safety, and Pharmacokinetics of RBD1016 and Tenofovir Alafenamide in Chronic Hepatitis D Virus Infection: A Phase 2a Multicentre TrialSweden SwedenNot Recruiting
Evaluation of Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RBD4059 in Stable Coronary Artery Disease Patients on Low-Dose AspirinSweden SwedenNot Recruiting
Phase 1 Randomized Double-Blind Placebo-Controlled Trial of RBD7007 in Complement-Mediated Diseases in Healthy ParticipantsSweden SwedenNot Yet Recruiting
Randomized active-controlled trial of safety and pharmacodynamics of two blinded doses of RBD4059 (vortosiran) versus apixaban in non-valvular atrial fibrillationDenmark DenmarkNorway NorwayPoland PolandSweden SwedenNot Yet Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
2
Exclusive Molecules
out of 6 total (33% not shared with other sponsors)

This sponsor works with 6 molecules, of which 2 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
15%
Return partnership rate
4 of 27 sites collaborated multiple times

This sponsor has worked with 27 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Cardiovascular Diseases3 trials
    359 other sponsors
  • 2.
    Immune System Diseases1 trial
    322 other sponsors
  • 3.
    Virus Diseases1 trial
    182 other sponsors

Partnered Research Centres

27 centres
location_city
assignment77
Aidport Sp. z o.o.
Address
Ul Ksiedza Stanisława Kozierowskiego 24, 60-185 Poznan
Learn morearrow_forward
location_city
assignment22
Akardo AB
Address
Lundagatan 23 Nb, Hogalid, 117 27 Stockholm
Learn morearrow_forward
location_city
assignment185
Akershus University Hospital
Address
Sykehusveien 25, 1474 Lorenskog
Learn morearrow_forward
location_city
assignment41
American Heart Of Poland S.A.
Address
Ul. Franklina Delano Roosevelta 2, 47-200 Kedzierzyn-Kozle
Learn morearrow_forward
location_city
assignment2
BALSAM MEDICA
Address
Goleszowska 1/U5, 01-249 Warsaw
Learn morearrow_forward
location_city
assignment9
Balsammedica Sp. z o.o.
Address
Ul. Goleszowska 1/U5, 01-249 Warsaw
Learn morearrow_forward
Page 1 of 5

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Ribocure Pharmaceuticals AB.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.